Cargando…

Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator

BACKGROUND: Anti-tachycardia pacing therapy (ATP) has shown comparable efficacy to shock therapy in ventricular tachycardia (VT) termination with better quality of life. However, some ATPs may lead to VT acceleration or degeneration to ventricular fibrillation (VF), which will result in more ICD sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awad, Sherien Samy, Azeez, Emmanuel Fares, Taha, Mohamed Ossama, El-Naggar, Wael Mohamed, El-Damaty, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236081/ https://www.ncbi.nlm.nih.gov/pubmed/37266828 http://dx.doi.org/10.1186/s43044-023-00369-y

Ejemplares similares

Tachycardia detection in modern implantable cardioverter–defibrillators
por: Brüggemann, Thomas, et al.
Publicado: (2016)

Pause-prevention pacing in an extravascular implantable cardioverter-defibrillator
por: Sagi, Venkata, et al.
Publicado: (2023)

A case of supraventricular tachycardia misdiagnosis after dual‐chamber implantable cardioverter defibrillator implantation with His bundle pacing
por: Sun, Xianchao, et al.
Publicado: (2023)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Dual tachycardia induced by electrocution terminated by an implantable cardioverter-defibrillator
por: Kocovic, Nikola, et al.
Publicado: (2023)

Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion
por: Honarbakhsh, Shohreh, et al.
Publicado: (2023)

Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review
por: De Maria, Elia, et al.
Publicado: (2017)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Transvenous implantable cardioverter-defibrillator implantation in a patient with arrhythmogenic cardiomyopathy and massive right atrial thrombus
por: Hayashi, Hiroshi, et al.
Publicado: (2020)

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
por: Bosman, Laurens P, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
por: Al-Ghamdi, Bandar, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
por: Orgeron, Gabriela M., et al.
Publicado: (2018)

Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies
por: Lane, Jem D., et al.
Publicado: (2018)

Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020)

Effectiveness of changing conventional implantable cardioverter-defibrillator settings to intrinsic antitachycardia pacing–like settings in the treatment of ventricular tachycardia in patients with cardiac failure
por: Tachibana, Motomi, et al.
Publicado: (2022)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
por: Mansour, Fadi, et al.
Publicado: (2019)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
por: Tsukahara, Keita, et al.
Publicado: (2021)

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
por: Regoli, François D., et al.
Publicado: (2023)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Misinterpretation of dual atrioventricular nodal non-reentrant tachycardia as ventricular tachycardia and implantation of implantable cardioverter-defibrillator followed by inappropriate shocks
por: Türkmen, Yusuf
Publicado: (2020)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
por: Orgeron, Gabriela M., et al.
Publicado: (2017)

Embodying a New Meaning of Being At Risk: Living With an Implantable Cardioverter Defibrillator for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Manuel, April, et al.
Publicado: (2016)

Anesthetic management in a patient with arrhythmogenic right ventricular cardiomyopathy and an implantable cardioverter defibrillator: a case report
por: Ohyama, Yoko, et al.
Publicado: (2020)

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD
por: Kutyifa, Valentina, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
por: Chemello, Diego, et al.
Publicado: (2012)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Ventricular Tachycardia Storm in a Patient with an Implanted Cardioverter-Defibrillator Following COVID-19 Infection
por: Kasinadhuni, Ganesh, et al.
Publicado: (2022)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hkmkj33c9segj0tt9jupd7nbt0